Apellis Pharmaceuticals, Inc. (APLS)

NASDAQ: APLS · Real-Time Price · USD

19.10

+0.59 (3.19%)

At close: Jun 5, 2025, 4:00 PM

19.34

+0.24 (1.26%)

After-hours: Jun 5, 2025, 7:00 PM EDT

Apellis Pharmaceuticals Market Cap

Apellis Pharmaceuticals has a market cap or net worth of $2.40 billion as of June 5, 2025. Its market cap has decreased by -52.12% in one year.

Market Cap

2.40B

Enterprise Value

2.51B

1-Year Change

-52.12%

Ranking

#1777

Market Cap Chart

Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.07M to $2.40B, an increase of 247.36%. That is a compound annual growth rate of 17.87%.

Market Cap History

Date	Market Cap	% Change
Jun 4, 2025	2.33B	-41.39%
Dec 31, 2024	3.97B	-44.04%
Dec 29, 2023	7.09B	24.06%
Dec 30, 2022	5.72B	24.22%
Dec 31, 2021	4.60B	6.25%
Dec 31, 2020	4.33B	121.45%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	686.22B
Johnson & Johnson	369.02B
AbbVie	332.08B
Novo Nordisk	324.15B
UnitedHealth Group	270.51B
Abbott Laboratories	232.29B
Novartis AG	229.87B
AstraZeneca	226.47B

Market Cap Rankings